Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications

Area of Science:

• Pharmacokinetics
• Drug Metabolism
• Clinical Pharmacology

Background:

• Theophylline pharmacokinetics literature presents conflicting reports of linear versus non-linear kinetics.
• Understanding theophylline's elimination kinetics is crucial for optimizing therapeutic drug monitoring.

Purpose of the Study:

• To reconcile conflicting reports on theophylline's pharmacokinetic behavior by applying Michaelis-Menten kinetics.
• To estimate key Michaelis-Menten parameters (Vmax and Km) for theophylline elimination in normal subjects.
• To utilize these parameters to explain dose-dependent oral clearances and predict various pharmacokinetic outcomes.

Main Methods:

• Utilized previously reported single-dose and steady-state theophylline clearance data from 10 normal subjects.
• Estimated pooled Vmax and Km values using the Michaelis-Menten equation.
• Applied the derived Vmax and Km to model oral clearances at different doses (2 and 6 mg/kg).
• Simulated bioavailability, AUC, Cssav, and CLsspo as functions of dose rate and input type.

Main Results:

• Pooled Vmax was estimated at 1960 mg/day and Km at 24.1 mg/L.
• The derived Michaelis-Menten parameters successfully explained differing oral clearances observed at various theophylline doses.
• Model predictions aligned with observed data regarding dose rate and input type effects on bioavailability.
• Calculations demonstrated alterations in apparent first-order elimination rate constant and half-life at sub-Km concentrations.

Conclusions:

• Theophylline exhibits Michaelis-Menten (non-linear) kinetics, explaining dose-dependent clearance and bioavailability.
• Accurate estimation of Vmax and Km provides a robust framework for predicting theophylline pharmacokinetics across different dosing scenarios.
• This approach clarifies previous discrepancies in the literature and enhances the understanding of theophylline's elimination behavior.